• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶-5表达增加与肝硬化大鼠肝脏中一氧化氮介导的血管舒张反应减弱有关。

Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers.

作者信息

Loureiro-Silva Mauricio R, Iwakiri Yasuko, Abraldes Juan G, Haq Omar, Groszmann Roberto J

机构信息

Hepatic Hemodynamic Laboratory, VA Medical Center, West Haven, CT 06516, USA.

出版信息

J Hepatol. 2006 May;44(5):886-93. doi: 10.1016/j.jhep.2006.01.032. Epub 2006 Feb 28.

DOI:10.1016/j.jhep.2006.01.032
PMID:16545481
Abstract

BACKGROUND/AIMS: Cirrhotic livers have a deficient vasodilator response to nitric oxide (NO). The vasodilator effect of NO is normally limited by the degradation of its second messenger cyclic guanosine 3', 5' monophosphate by phosphodiesterases. We investigated (1) the phosphodiesterase-5 (PDE-5) expression in normal and cirrhotic rat livers, (2) the location of the deficient response to NO in cirrhotic livers, and (3) the effect of the PDE-5 inhibitor Sildenafil citrate on this deficient response.

METHODS

Normal and ascitic cirrhotic rats were subjected to liver perfusion with continuous measurement of both perfusion and sinusoidal (wedge hepatic) pressures. After incubation with N-monomethyl-l-arginine and pre-constriction with Methoxamine, concentration-response curves to the spontaneous NO donor S-nitroso-N-acetylpenicillamine were obtained in the absence or presence of Sildenafil (10(-8)M).

RESULTS

PDE-5 expression (Western blot) in cirrhotic livers was higher than in normal livers (P=0.042). Compared to normal livers, cirrhotic livers showed a decreased response to S-nitroso-N-acetylpenicillamine in the pre-sinusoidal area (P=0.003) but not in the sinusoidal/post-sinusoidal area (P=0.433). In the presence of Sildenafil, normal and cirrhotic livers showed similar pre-sinusoidal (P=0.419) and sinusoidal/post-sinusoidal (P=0.875) responses to S-nitroso-N-acetylpenicillamine.

CONCLUSIONS

Increased PDE-5 expression is involved in the decreased vascular response to NO in cirrhotic livers.

摘要

背景/目的:肝硬化肝脏对一氧化氮(NO)的血管舒张反应不足。NO的血管舒张作用通常受到磷酸二酯酶对其第二信使环磷酸鸟苷3',5'-单磷酸的降解的限制。我们研究了(1)正常和肝硬化大鼠肝脏中磷酸二酯酶-5(PDE-5)的表达,(2)肝硬化肝脏中对NO反应不足的部位,以及(3)PDE-5抑制剂枸橼酸西地那非对这种反应不足的影响。

方法

对正常和腹水型肝硬化大鼠进行肝脏灌注,并持续测量灌注压和肝窦(楔形肝)压力。在用N-单甲基-L-精氨酸孵育并经甲氧明预收缩后,在不存在或存在西地那非(10⁻⁸M)的情况下,获得对自发性NO供体S-亚硝基-N-乙酰青霉胺的浓度-反应曲线。

结果

肝硬化肝脏中PDE-5的表达(蛋白质印迹法)高于正常肝脏(P = 0.042)。与正常肝脏相比,肝硬化肝脏在肝窦前区域对S-亚硝基-N-乙酰青霉胺的反应降低(P = 0.003),但在肝窦/肝窦后区域无此现象(P = 0.433)。在存在西地那非的情况下,正常和肝硬化肝脏对S-亚硝基-N-乙酰青霉胺的肝窦前(P = 0.419)和肝窦/肝窦后(P = 0.875)反应相似。

结论

PDE-5表达增加与肝硬化肝脏中血管对NO的反应降低有关。

相似文献

1
Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers.磷酸二酯酶-5表达增加与肝硬化大鼠肝脏中一氧化氮介导的血管舒张反应减弱有关。
J Hepatol. 2006 May;44(5):886-93. doi: 10.1016/j.jhep.2006.01.032. Epub 2006 Feb 28.
2
Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas.肝硬化大鼠肝脏中一氧化氮生成的缺陷位于肝血窦和肝血窦后区域。
Am J Physiol Gastrointest Liver Physiol. 2003 Apr;284(4):G567-74. doi: 10.1152/ajpgi.00452.2002. Epub 2002 Dec 18.
3
Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers.肝硬化大鼠肝脏中硝酸甘油的生物活化及对一氧化氮的血管舒缩反应受损。
Hepatology. 2002 Aug;36(2):381-5. doi: 10.1053/jhep.2002.34739.
4
Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.磷酸二酯酶5抑制剂对胎羊肺血管反应性的影响。
Ann Thorac Surg. 2006 Mar;81(3):935-42. doi: 10.1016/j.athoracsur.2005.09.022.
5
Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats.肝硬化大鼠肝内微循环中的内皮功能障碍及一氧化氮生成减少。
Hepatology. 1998 Oct;28(4):926-31. doi: 10.1002/hep.510280405.
6
Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.西地那非(万艾可)可引起视网膜小动脉扩张:通过一氧化氮合酶激活和磷酸二酯酶抑制的双重途径。
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):720-5. doi: 10.1167/iovs.07-1208.
7
The presence and function of phosphodiesterase type 5 in the rat myometrium.大鼠子宫肌层中5型磷酸二酯酶的存在及功能
Am J Obstet Gynecol. 2004 Jan;190(1):268-74. doi: 10.1016/j.ajog.2003.07.006.
8
Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aorta.5型磷酸二酯酶抑制剂枸橼酸西地那非不能增强奈必洛尔对大鼠主动脉的舒张特性。
Life Sci. 2006 Feb 2;78(10):1103-7. doi: 10.1016/j.lfs.2005.06.051. Epub 2005 Nov 16.
9
Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.鞘内注射吗啡可抑制炎性爪肿胀:一氧化氮和环磷酸鸟苷的作用
Anesth Analg. 2008 Mar;106(3):965-71, table of contents. doi: 10.1213/ane.0b013e318162cebf.
10
Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.低剂量西地那非治疗 1 周可降低胆汁性肝硬化大鼠肝内阻力:与 NO 生物利用度的关系。
Clin Sci (Lond). 2010 Apr 7;119(1):45-55. doi: 10.1042/CS20090601.

引用本文的文献

1
From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension.从病理生理学到临床实践:门静脉高压症不断发展的药物治疗、临床并发症及药物遗传学考量
Metabolites. 2025 Jan 23;15(2):72. doi: 10.3390/metabo15020072.
2
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications.环鸟苷酸在肝硬化中的作用——门脉高压病理生理学中的作用和治疗意义。
Int J Mol Sci. 2021 Sep 26;22(19):10372. doi: 10.3390/ijms221910372.
3
Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis.
单细胞转录组学揭示肝硬化时肝窦内皮细胞的区域特异性改变。
Cell Mol Gastroenterol Hepatol. 2021;11(4):1139-1161. doi: 10.1016/j.jcmgh.2020.12.007. Epub 2020 Dec 16.
4
Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension.肝脏中的磷酸二酯酶作为肝硬化门脉高压的潜在治疗靶点。
Int J Mol Sci. 2020 Aug 28;21(17):6223. doi: 10.3390/ijms21176223.
5
Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.实验性肝硬化中环鸟苷酸-一氧化氮通路分析表明磷酸二酯酶-5 可能是治疗门脉高压的靶点。
World J Gastroenterol. 2018 Oct 14;24(38):4356-4368. doi: 10.3748/wjg.v24.i38.4356.
6
Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.磷酸二酯酶-5 抑制剂对肝硬化门脉高压的长期有益影响:一例 8 年随访病例报告。
World J Gastroenterol. 2018 Jan 21;24(3):438-444. doi: 10.3748/wjg.v24.i3.438.
7
Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.门静脉高压症病理生理学和治疗学的新进展:新的治疗方法即将出现。
Hepatol Int. 2018 Feb;12(Suppl 1):112-121. doi: 10.1007/s12072-017-9806-1. Epub 2017 Jul 11.
8
The effects of tadalafil and pentoxifylline on apoptosis and nitric oxide synthase in liver ischemia/reperfusion injury.他达拉非和己酮可可碱对肝脏缺血/再灌注损伤中细胞凋亡和一氧化氮合酶的影响。
Kaohsiung J Med Sci. 2016 Jul;32(7):339-47. doi: 10.1016/j.kjms.2016.05.005. Epub 2016 Jun 2.
9
Sildenafil attenuates hepatocellular injury after liver ischemia reperfusion in rats: a preliminary study.西地那非减轻大鼠肝脏缺血再灌注后的肝细胞损伤:一项初步研究。
Oxid Med Cell Longev. 2014;2014:161942. doi: 10.1155/2014/161942. Epub 2014 Jun 4.
10
Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis.西地那非改善自发性动脉粥样硬化实验模型中遗传毒性的生物标志物。
Lipids Health Dis. 2013 Aug 28;12:128. doi: 10.1186/1476-511X-12-128.